Jonathan Chang
Stock Analyst at Leerink Partners
(0)
# 4948
Out of 5,243 analysts
131
Total ratings
18.06%
Success rate
-32.62%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Vincerx Pharma | Maintains: Outperform | 4 2 | 0.15 | 1233.33% | 6 | Oct 8, 2024 | |
Immunocore Hldgs | Initiates Coverage On: Outperform | 74 | 29.39 | 151.79% | 1 | Apr 29, 2024 | |
Nanobiotix | Initiates Coverage On: Outperform | 11 | 2.94 | 274.15% | 1 | Dec 8, 2023 | |
NovoCure | Initiates Coverage On: Outperform | 51 | 26.39 | 93.26% | 1 | Aug 4, 2023 | |
Karyopharm Therapeut... | Maintains: Market Perform | 6 5 | 0.63 | 693.65% | 12 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 10.4 | 226.92% | 9 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 18 2 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 40 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 33 | 20.27 | 62.8% | 9 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 3 2 | n/a | n/a | 7 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 50 | 14.57 | 243.17% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 30 | 39.91 | -24.83% | 4 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 3.21 | 273.83% | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 1 | n/a | n/a | 7 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 14 | 0.64 | 2087.5% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 26 | 5.75 | 352.17% | 5 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 101 95 | 24.6 | 286.18% | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 60 | n/a | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 3 | 0.61 | 391.8% | 8 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | n/a | n/a | 5 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 28 | 7.22 | 287.81% | 3 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 53 | 20.05 | 164.34% | 7 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 50 0 | n/a | n/a | 2 | May 10, 2018 |